eMedicine Specialties > Physical Medicine and Rehabilitation > Traumatic Brain Injury

Post Head Injury Endocrine Complications

Author: Milton J Klein, DO, MBA, Consulting Physiatrist, Sewickley Valley Hospital, Allegheny General Hospital, Harmarville Rehabilitation Center, Ohio Valley General Hospital, and Aliquippa Community Hospital
Contributor Information and Disclosures

Updated: Jan 5, 2009

Introduction

Background

The greatest challenge associated with endocrine complications in individuals with traumatic brain injury (TBI) is early recognition of these subtle problems. Endocrine complications can produce significant impact on the progress and outcome of TBI rehabilitation. Prompt diagnosis and treatment of endocrine complications following TBI facilitate the rehabilitation process of patients with TBI.

The release of pituitary hormones, orchestrated by the neuropeptide signals from the hypothalamus, provides a tight control of hormone-regulated homeostasis. The pituitary gland is protected well within the sella turcica of the sphenoid bone; however, the pituitary stalk, connected to the anterior pituitary and hypothalamus, is vulnerable to the effects of TBI, especially in patients with associated facial fractures, cranial nerve injuries, and dysautonomia.

Related eMedicine topics:
Classification and Complications of Traumatic Brain Injury
Head Trauma [Pediatrics: Cardiac Disease and Critical Care Medicine]
Head Trauma [Trauma]
Post Head Injury Autonomic Complications
Traumatic Brain Injury: Definition, Epidemiology, Pathophysiology

Pathophysiology

Autopsy studies in fatal traumatic brain injury (TBI) cases demonstrate a fairly high prevalence of hypothalamic and pituitary abnormalities, including anterior lobe necrosis, posterior lobe hemorrhage, and traumatic lesions of the hypothalamic-pituitary stalk. Some variability is noted in studies. Anterior pituitary infarction has been seen to occur in 9-38% of patients; posterior pituitary hemorrhage, in 12-45% of cases; and traumatic lesions of the stalk, in 5-30% of patients.

The traumatic rupture of the pituitary stalk results in anterior lobe infarction because of disruption of the portal blood supply between the hypothalamus and anterior pituitary. Ninety percent of the anterior lobe is nourished by the hypophyseal portal veins, which originate from and follow the pituitary stalk. An alternative explanation is that posttraumatic edema of the pituitary gland within the bony sella turcica compromises the portal blood supply, resulting in anterior lobe ischemia/necrosis. Both mechanisms may contribute to anterior lobe dysfunction following TBI.

Anterior hypothalamic trauma often is observed on postmortem studies and may be associated with pituitary hemorrhage or infarction related to TBI. Anterior pituitary hormones (eg, growth hormone [GH],1 thyrotropin, corticotropin, gonadotropins) are released by the neuropeptide-releasing hormones from the hypothalamus. The posterior pituitary hormones (eg, vasopressin, oxytocin) are produced by the hypothalamus and are carried by long axonal projections into the posterior pituitary; they are released later. The posterior lobe vascular supply is not affected by pituitary stalk trauma, because it is supplied by the inferior hypophyseal arteries, which arise from the internal carotid artery below the level of the diaphragma sella. Infarction of the posterior lobe is therefore rare, and the mechanism of the development of diabetes insipidus (DI) is by denervation-losing neural integrity with the hypothalamus.2,3,4,5,6,7

The most common endocrine complication after a TBI is syndrome of inappropriate antidiuretic hormone (SIADH). SIADH causes a dilutional hyponatremia secondary to inappropriate renal water conservation. Relatively less common post-TBI endocrinopathies include anterior hypopituitarism (AH), DI, cerebral salt wasting (CSW), and primary adrenal insufficiency (PAI).8,9,10,11,12,13,14,15 The most common endocrinopathies associated with hypopituitarism, in descending order, include hypogonadism, hypothyroidism, adrenal insufficiency, hyperprolactinemia, DI, and GH deficiency. CSW and PAI are peripheral causes of hyponatremia after a TBI. SIADH, AH, and DI have central endocrine etiologies.

Frequency

United States

In the United States, the annual incidence of traumatic brain injury (TBI) is 1.5-2 million people.16 Of that population, 70,000-90,000 persons sustain a chronic, significant disabling condition. A retrospective study demonstrated that 4% of patients with TBI sustained an associated neuroendocrine disorder of the hypothalamic-pituitary axis. This condition is underdiagnosed,17,18 as demonstrated by evidence that 40-63% of fatal cases of TBI reveal postmortem pathologic findings of the hypothalamus/anterior pituitary.

Mortality/Morbidity

According to data from the Centers for Disease Control and Prevention, state surveillance projects report the annual incidence of traumatic brain injury (TBI) to be 200 individuals per 100,000 people, with an estimated 52,000 fatalities each year. Estimates of prevalence suggest that a total of 2.5-6.5 million persons are living with the sequelae of TBI. These estimates may be inaccurate, because these data are limited to hospitalized patients with TBI and to prehospital fatalities from TBI.

Race

No known statistical racial predisposition exists in relation to traumatic brain injury (TBI). Approximately 20% of TBI cases are related to violence, especially firearm violence. In general, young African-American males are exposed to violent acts more frequently than other populations are, which may be reflected in a somewhat higher-than-average incidence of TBI in this group.

Sex

The male-to-female ratio for the incidence of traumatic brain injury (TBI) is greater than 2:1. The incidence of neuroendocrine complications following TBI is directly proportional to this ratio.

Age

The populations at greatest risk for traumatic brain injury are young people aged 15-24 years and individuals older than 75 years. Children aged 5 years or younger also are at risk.1

Clinical

History

Approximately 30-50% of patients who survive post–traumatic brain injury (post-TBI) demonstrate endocrine complications. Most post-TBI endocrinopathies do not have typical specific history patterns.

  • Diabetes insipidus (DI) is an exception, as it does have a specific history. DI most commonly is associated with severe TBI and basilar skull fractures with cranial nerve involvement, craniofacial trauma, and postcardiopulmonary arrest. Delayed onset of DI is associated with a poor prognosis due to hypothalamic involvement causing permanent DI. Acute DI following a mild to moderate TBI indicates a posterior pituitary lesion with only a temporary antidiuretic hormone (ADH) deficiency.
  • Anterior hypopituitarism (AH) also has a specific history. AH usually is associated with moderate to severe TBI. With improvement of emergency and neurosurgical care for these patients, there are more survivors demonstrating AH. AH may present weeks to months after the TBI, typically in the acute or chronic rehabilitation phase. Any patient with unexplained malaise or a setback with regard to functional status should be examined and tested for AH or the other post-TBI endocrinopathies. In summary, risk factors for AH include relatively serious TBI (Glasgow Coma Scale score <10), diffuse brain swelling, and hypotensive or hypoxic episode.
  • Syndrome of inappropriate antidiuretic hormone is the most common TBI-associated neuroendocrinopathy causing hyponatremia. The incidence is reportedly as high as 33%.19
  • Cerebral salt wasting (CSW) is a less common cause of hyponatremia in the post-TBI population. These patients are dehydrated and lose weight.
  • Primary adrenal insufficiency (PAI) is rare and presents with the superimposed psychiatric symptoms of depression, confusion, and apathy. PAI is associated with fatigue, weakness, anorexia, and weight loss. These problems may present insidiously over a prolonged period. The acute presentation of PAI includes nausea, vomiting, and hypertension.

Related eMedicine topics:
Adrenal Insufficiency
Adrenal Insufficiency and Adrenal Crisis
Cerebral Salt-Wasting Syndrome
Diabetes Insipidus [Endocrinology]
Diabetes Insipidus [Pediatrics: General Medicine]
Hypopituitarism [Emergency Medicine]
Hypopituitarism [Pediatrics: General Medicine]
Hypopituitarism (Panhypopituitarism)
Panhypopituitarism
Syndrome of Inappropriate Antidiuretic Hormone Secretion [Emergency Medicine]
Syndrome of Inappropriate Antidiuretic Hormone Secretion [Pediatrics: General Medicine]
Syndrome of Inappropriate Secretion of Antidiuretic Hormone [Nephrology]

Physical

  • Physical examination findings may be obscured by the altered cognitive status of patients who have had a traumatic brain injury (TBI).
  • Common post-TBI findings, such as lethargy, fatigue, and slowed mental processing time, also are associated with endocrine complications.
  • In extreme cases, hyponatremia can cause seizures, confusion, and coma.
  • Primary adrenal insufficiency (PAI) may present with acute psychiatric problems, such as psychosis, depression, apathy, or a schizophrenialike syndrome.
  • General physical examination findings may include myxedematous, addisonian-appearing, or slowed mentation.
  • Vital signs include the following:
    • Slowed pulse
    • Hypothermia
    • Orthostatic hypotension
  • Dermatologic findings include the following:
    • Pale, soft, waxy skin
    • Hyperpigmentation
    • Decreased axillary and pubic hair
    • Areolar depigmentation
    • Decreased male facial hair
    • Decreased sweating and sebum secretion
  • Neurologic findings include the following:
    • Mental status changes (eg, lethargy, confusion, slowed mentation)
    • Muscle weakness (may be proximal due to endocrine myopathy)
    • Hyporeflexia or areflexia
    • Hypotonia

Causes

The most common post–traumatic brain injury (post-TBI) endocrine complications are as follows:

  • Syndrome of inappropriate antidiuretic hormone (SIADH)19
    • SIADH is the most common neuroendocrine complication following TBI, with a reported incidence of as high as 33%. In the TBI rehabilitation setting, SIADH is the most common cause of hyponatremia.
    • Hyponatremia often is seen in the rehabilitation setting among survivors of either traumatic or nontraumatic brain injury (eg, hemorrhagic stroke, brain tumors, CNS infections). This problem is associated most often with SIADH. Approximately 30% of patients who undergo neurosurgery demonstrate SIADH. SIADH also can be induced by medications such as carbamazepine, major tranquilizers, and antidepressants.
    • Hyponatremia can cause several problems, including cerebral ischemia (by volume depletion), lassitude, seizures, confusion, and coma.
    • SIADH causes renal water conservation, with a secondary hyponatremia because of dilution. In patients who are not dehydrated or using diuretics, the laboratory diagnosis is based upon a urine osmolality greater than serum osmolality. The serum osmolality in patients with SIADH is less than 280 osm/kg, serum sodium is less than 135 mEq/L, and urine sodium is greater than 25 mEq/L.
    • The treatment in most cases is fluid restriction and, in unusual situations, IV hypertonic saline.
  • Cerebral salt wasting (CSW)14
    • Although most cases of hyponatremia due to brain injury are caused by SIADH, a less common etiology is CSW syndrome. Peters and colleagues first described CSW in 1950.13 CSW is caused by impaired renal tube function that results in the inability of the kidneys to conserve salt. The etiology may be attributable to direct neural influence on renal tube function. Salt wasting with volume depletion is the hallmark of this syndrome. Clinically, patients manifesting CSW are dehydrated, lose weight, have orthostatic hypotension, and demonstrate a negative fluid balance. In cases of CSW and SIADH, the laboratory values often are the same for serum/urine osmolalities and electrolytes; however, elevated serum blood urea nitrogen (BUN), serum potassium, and serum protein concentration also are supportive of the diagnosis of CSW. Additionally, serum uric acid is normal in patients with CSW and is low in persons with SIADH.
    • Treatment of this type of hyponatremia with associated dehydration consists of replacement of fluids and salt, which is best managed by IV normal saline or, in rare cases, by IV hypertonic saline. Rehydration significantly reduces the risk of cerebral ischemia or cerebrovascular accident.
  • Diabetes insipidus (DI)2,3,4,5,6,7
    • DI is rare, with an estimated 1 case per 100,000 hospital admissions. Posttraumatic DI occurs in 2-16% of all cases. The most common etiologies of posttraumatic DI include severe closed head injury, frequently with basilar skull fractures; craniofacial trauma; thoracic injury; postcardiopulmonary arrest; and intraventricular hemorrhage in neonatal patients. DI frequently is associated with cranial nerve injuries. The usual onset is 5-10 days following trauma.
    • Characteristic features of DI include polyuria, low urine osmolality, high serum osmolality, normal serum glucose, and normal to elevated serum sodium. Urine output usually is greater than 90 mL/kg/d, with a specific gravity of less than 1.010 and an osmolality of 50-200 mOsm.
  • Anterior hypopituitarism (AH)8,9,10,11,12
    • AH, or panhypopituitarism, is not as rare a complication after a closed head injury; it usually follows moderate to severe craniocerebral trauma. With improvements in emergency and acute neurosurgical care for patients with head injuries, a greater number of severely involved patients are surviving than had previously done so. This subset of patients is most susceptible to the development of AH. The mechanism through which AH develops in patients with severe head injuries is an interruption of the major blood supply to the anterior lobe of the pituitary gland because of trauma to the unprotected stalk connecting the anterior pituitary to the median eminence of the hypothalamus.
    • Additionally, the hypothalamus secretes releasing and inhibitory hormones into the portal or stalk circulation, for controlling the release of the anterior pituitary hormones. Although the pituitary gland is well protected by the bony sella turcica, the pituitary stalk is not covered by dura mater and lies in the subarachnoid space. Severe craniocerebral injury may traumatize the stalk directly, or an anterior lobe infarction can occur due to impaired portal system circulation secondary to shock and cerebral edema.
    • The arterial blood supply of the posterior lobe of the pituitary comes directly from the inferior hypophyseal arteries branching from the internal carotid arteries. The posterior pituitary hormones are secreted by the hypothalamus.
    • Autopsy studies of 100 patients who died from craniocerebral trauma demonstrated pituitary lesions in approximately 60% of the group studied. Of those subjects with pituitary lesions, 59 demonstrated capsular hemorrhage, 42 demonstrated posterior lobe hemorrhages, and 22 revealed anterior lobe ischemic necrosis. Most patients (20 of 22) with anterior lobe ischemic necrosis died within the first 7 days following injury because of the severity of the craniocerebral trauma associated with shock and severe cerebral edema. Clinical AH is so rare in association with closed head injuries because most of these patients do not survive secondary to the severity of their injuries. This clinical syndrome presents itself only when two thirds of the anterior pituitary has been destroyed.
    • The syndrome of AH may manifest an insidious onset weeks to months after the original closed head injury. The patient may become progressively lethargic or anorexic and may demonstrate hypothermia, bradycardia, or hypotension with hyponatremia. These symptoms result in a significant setback if they occur during the acute phase of rehabilitation of a patient who has sustained a closed head injury. Any unexplained onset of malaise and generally decreased vital signs with associated stagnation of the rehabilitation progress in a patient following closed head injury should prompt the clinician to suspect the presence of AH.
    • AH following TBI can be obscured by the cognitive impairment of the patient and can contribute to delayed progress in rehabilitation.
    • The endocrine workup for AH includes serum hormonal assays, such as cortisol (0900), testosterone, triiodothyronine (T3), thyroxine (T4), thyrotropin, follicle-stimulating hormone (FSH), luteinizing hormone (LH), and estrogen (females). Insulinlike growth factor-I (IGF-I) is a screening assay for growth hormone (GH) deficiency. Advanced provocative GH testing may be necessary to confirm this diagnosis. Also perform a complete blood cell (CBC) count and serum electrolyte evaluation.
    • Treatment involves multiple hormonal replacement therapy, as well as monitoring of the patient's serum levels and clinical response. The patient usually responds with improved vital signs, improved constitutional symptoms, and increased endurance for participation and progress in the rehabilitation program. The hormonal replacement therapy usually is required long-term.
  • Primary adrenal insufficiency (PAI)15
    • PAI usually presents with the psychiatric symptoms of depression, confusion, and apathy.
    • Additional features include self-mutilation, paranoia, psychosis, and schizophrenic behaviors.
    • The mechanism of the psychiatric presentation is related to factors such as hypoglycemia, elevated exogenous endorphins, and axonal conduction changes.
    • Progressive deficiency of glucocorticoid and mineralocorticoid hormonal activity leads to hypotension, fatigue, anorexia/nausea, hyperpigmentation, and progressive, generalized weakness. Diagnosis of PAI is difficult in patients with TBI, because these particular symptoms may be ascribed to the TBI itself.
    • The most common cause of PAI is autoimmune or idiopathic adrenalitis (in 65-84% of cases). The next most common etiology is adrenal parenchymal destruction secondary to tuberculosis, sarcoidosis, malignancy, acute sepsis (including systemic fungal infections), and acquired immunodeficiency syndrome (AIDS).
    • Acute adrenal crisis may result from bilateral adrenal hemorrhage from trauma, sepsis, surgery, or acute burns. If this problem is unrecognized, acute adrenal crisis may lead to acute shock and death. Adrenal failure usually is permanent in patients who survive the acute phase of the adrenal crisis.
    • Several rare hereditary syndromes are associated with PAI, such as familial glucocorticoid insufficiency, adrenoleukodystrophy, and adrenomyeloneuropathy. PAI results from a deficiency of glucocorticoid and mineralocorticoid hormonal activity, combined with a reduction of feedback to the anterior pituitary gland. The cortisol deficiency results in excessive secretion of corticotropin from the anterior pituitary gland and excessive secretion of corticotropin-releasing hormone from the hypothalamus.
    • The presentation of PAI may be acute, characterized by nausea, vomiting, and hypertension. Alternatively, this clinical entity may present insidiously, with slow development of nonspecific symptoms over a prolonged period. The most common features include fatigue, weakness, anorexia, and weight loss. Additional findings include hyponatremia, hyperkalemia, skin hyperpigmentation, and gastric motility impairment that leads to complete gastric stasis.
    • Physiatrists must be aware of PAI, even though it is rare, because the presentation of adrenal insufficiency can be similar to the presentation of TBI. The symptoms limiting rehabilitation of patients following TBI can be attributed to the brain injury itself or to deconditioning secondary to prolonged bedrest. Treatment of this underlying problem by mineralocorticoid and glucocorticoid replacement therapy can result in a significant improvement of rehabilitation progress and outcome.
  • Other post-TBI endocrine complications
    • Early puberty is defined as secondary sexual development in females younger than 8 years and in males younger than 9 years. Precocious puberty can occur in children with head injuries because of an inappropriate secretion of gonadotropin-releasing hormone (GRH), resulting in the subsequent release from the anterior pituitary of LH and FSH. These hormones cause the early onset of puberty by increasing levels of gonadal steroids and gametogenesis.
    • Hypogonadism also can occur following head trauma. In one study, approximately one third of female patients who had head injuries (ie, 26 of 78) experienced temporary amenorrhea, usually for no longer than 3 months. This phenomenon is secondary to hypothalamic dysfunction, resulting in absent or decreased secretion of GRH.
    • In male patients, gonadotropin and testosterone levels are low immediately following head injury. Later, in response to exogenous GRH, the anterior pituitary responds with the release of high levels of LH and FSH, which is typical of hypothalamic dysfunction. At 3-6 months after the head injury, 5 of 21 male patients demonstrated persistently low serum testosterone levels. Depending on the clinical situation, consider appropriate testosterone replacement therapy.
  • Summary
    • Approximately 30-50% of patients with moderate-to-severe head injury demonstrate endocrine complications. These problems may not present in a classic textbook fashion in persons who are severely impaired following TBI. The only clue to determining endocrine complications may be an unexplained failure to progress or a setback in the TBI rehabilitation program.
    • The most common endocrine abnormality is SIADH, followed by DI.
    • SIADH is the most common cause of hyponatremia; however, other causes include fluid overload or extracellular fluid depletion from GI or renal loss of sodium.
    • Criteria for diagnosis of SIADH include low serum osmolality, hyponatremia, and inappropriately concentrated urine (with urine sodium >25 mEq/L).
    • Hyponatremia that remains unresponsive to standard treatment for SIADH should point the clinician to other causes of hyponatremia.
    • Another clue to recognizing adrenal insufficiency is hyperkalemia associated with the hyponatremia secondary to a loss of mineralocorticoid activity at the kidney, causing urine sodium loss, impaired excretion of potassium, and hydrogen ion retention.
    • Azotemia also may be associated with adrenal insufficiency.

More on Post Head Injury Endocrine Complications

Overview: Post Head Injury Endocrine Complications
Differential Diagnoses & Workup: Post Head Injury Endocrine Complications
Treatment & Medication: Post Head Injury Endocrine Complications
Follow-up: Post Head Injury Endocrine Complications
Multimedia: Post Head Injury Endocrine Complications
References

References

  1. Acerini CL, Tasker RC. Neuroendocrine consequences of traumatic brain injury. J Pediatr Endocrinol Metab. Jul 2008;21(7):611-9. [Medline].

  2. Hadani M, Findler G, Shaked I, et al. Unusual delayed onset of diabetes insipidus following closed head trauma. Case report. J Neurosurg. Sep 1985;63(3):456-8. [Medline].

  3. Levitt MA, Fleischer AS, Meislin HW. Acute post-traumatic diabetes insipidus: treatment with continuous intravenous vasopressin. J Trauma. Jun 1984;24(6):532-5. [Medline].

  4. Notman DD, Mortek MA, Moses AM. Permanent diabetes insipidus following head trauma: observations on ten patients and an approach to diagnosis. J Trauma. Jul 1980;20(7):599-602. [Medline].

  5. Shucart WA, Jackson I. Management of diabetes insipidus in neurosurgical patients. J Neurosurg. Jan 1976;44(1):65-71. [Medline].

  6. Tatoian JA Jr, LaDow CS Jr, Diamond MC. Permanent posttraumatic diabetes insipidus. J Oral Surg. Jul 1975;33(7):548-51. [Medline].

  7. Ward MK, Fraser TR. DDAVP in treatment of vasopressin-sensitive diabetes insipidus. Br Med J. Jul 13 1974;3(923):86-9. [Medline].

  8. Klingbeil GE, Cline P. Anterior hypopituitarism: a consequence of head injury. Arch Phys Med Rehabil. Jan 1985;66(1):44-6. [Medline].

  9. Mitchell A, Steffenson N, Davenport K. Hypopituitarism due to traumatic brain injury: a case study. Crit Care Nurse. Aug 1997;17(4):34-7, 40-2, 46-51; quiz 53-4. [Medline].

  10. Soules MR, Sheldon GW. Traumatic hypopituitarism: anterior hypophyseal insufficiency from indirect cranial trauma. South Med J. Dec 1979;72(12):1592-6. [Medline].

  11. Valenta LJ, De Feo DR. Post-traumatic hypopituitarism due to a hypothalamic lesion. Am J Med. Apr 1980;68(4):614-7. [Medline].

  12. Winternitz WW, Dzur JA. Pituitary failure secondary to head trauma. Case report. J Neurosurg. Apr 1976;44(4):504-5. [Medline].

  13. Peters J, Welt L, Sims E. A salt wasting syndrome associated with cerebral disease. Trans Assoc Am Physiol. 1950;63:57-64.

  14. Zafonte RD, Mann NR. Cerebral salt wasting syndrome in brain injury patients: a potential cause of hyponatremia. Arch Phys Med Rehabil. May 1997;78(5):540-2. [Medline].

  15. Powner DJ, Boccalandro C. Adrenal insufficiency following traumatic brain injury in adults. Curr Opin Crit Care. Apr 2008;14(2):163-6. [Medline].

  16. Thurman DJ, Alverson C, Dunn KA, et al. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. Dec 1999;14(6):602-15. [Medline].

  17. [Best Evidence] Behan LA, Phillips J, Thompson CJ, et al. Neuroendocrine disorders after traumatic brain injury. J Neurol Neurosurg Psychiatry. Jul 2008;79(7):753-9. [Medline].

  18. De Sanctis V, Sprocati M, Govoni M R, et al. Assessment of traumatic brain injury and anterior pituitary dysfunction in adolescents. Georgian Med News. Mar 2008;18-23. [Medline].

  19. Born JD, Hans P, Smitz S, et al. Syndrome of inappropriate secretion of antidiuretic hormone after severe head injury. Surg Neurol. Apr 1985;23(4):383-7. [Medline].

  20. Makulski DD, Taber KH, Chiou-Tan FY. Neuroimaging in posttraumatic hypopituitarism. J Comput Assist Tomogr. Mar-Apr 2008;32(2):324-8. [Medline].

  21. Adrogue HJ, Madias NE. Hyponatremia. N Engl J Med. May 25 2000;342(21):1581-9. [Medline].

  22. Anmuth CJ, Ross BW, Alexander MA, et al. Chronic syndrome of inappropriate secretion of antidiuretic hormone in a pediatric patient after traumatic brain injury. Arch Phys Med Rehabil. Nov 1993;74(11):1219-21. [Medline].

  23. Childers MK, Rupright J, Jones PS, et al. Assessment of neuroendocrine dysfunction following traumatic brain injury. Brain Inj. Jun 1998;12(6):517-23. [Medline].

  24. Hansen JR, Cook JS. Post-traumatic neuroendocrine disorders. In: Physical Medical and Rehabilitation: State of the Art Reviews. vol 7. Philadelphia, Pa: Hanley & Belfus; 1993:569-80.

  25. Hays RM, Levine SD. Vasopressin. Kidney Int. Nov 1974;6(5):307-22. [Medline].

  26. McLaurin RL, King LR. Recognition and treatment of metabolic disorders after head injuries. Clin Neurosurg. 1972;19:281-300. [Medline].

  27. National Institutes of Health. Rehabilitation of Persons with Traumatic Brain Injury. NIH Consensus Statement. 1998;16:1-41.

  28. Physicians' Desk Reference. vol 54. Oradell, NJ: Medical Economics; 2000:515-8; 1513-6; 1529-30; 1765-6; 1968-9; 2553-6.

  29. Trost HA, Gaab MR. Plasma osmolality, osmoregulation and prognosis after head injury. Acta Neurochir (Wien). 1992;116(1):33-7. [Medline].

  30. Vingerhoets F, de Tribolet N. Hyponatremia hypo-osmolarity in neurosurgical patients. "Appropriate secretion of ADH" and "cerebral salt wasting syndrome". Acta Neurochir (Wien). 1988;91(1-2):50-4. [Medline].

  31. Webster JB, Bell KR. Primary adrenal insufficiency following traumatic brain injury: a case report and review of the literature. Arch Phys Med Rehabil. Mar 1997;78(3):314-8. [Medline].

  32. Werbel SS, Ober KP. Acute adrenal insufficiency. Endocrinol Metab Clin North Am. Jun 1993;22(2):303-28. [Medline].

  33. Zafonte R, Muizelaar JP, Peterson PL. The pathophysiology of brain injury: understanding innovative drug therapies. J Head Trauma Rehabil. Feb 1998;13(1):1-10. [Medline].

Further Reading

Keywords

hormone, hormones, adrenal, endocrine, TBI, head injury, adrenal gland, traumatic brain injury, pituitary gland, endocrine system, hypothalamus, adrenal insufficiency, adrenal glands, pituitary glands, hypopituitarism, panhypopituitarism, posttraumatic brain injury endocrine complications, post-traumatic brain injury endocrine complications, endocrine complications following TBI

Contributor Information and Disclosures

Author

Milton J Klein, DO, MBA, Consulting Physiatrist, Sewickley Valley Hospital, Allegheny General Hospital, Harmarville Rehabilitation Center, Ohio Valley General Hospital, and Aliquippa Community Hospital
Milton J Klein, DO, MBA is a member of the following medical societies: American Academy of Disability Evaluating Physicians, American Academy of Medical Acupuncture, American Academy of Osteopathy, American Academy of Physical Medicine and Rehabilitation, American Medical Association, American Osteopathic Association, American Osteopathic College of Physical Medicine and Rehabilitation, American Pain Society, and Pennsylvania Medical Society
Disclosure: Nothing to disclose.

Medical Editor

Patrick J Potter, BSc, MD, FRCP(C), Associate Professor, Physical Medicine and Rehabilitation, The University of Western Ontario; Consulting Staff, Department of Physical Medicine and Rehabilitation, St Joseph's Health Care Centre
Patrick J Potter, BSc, MD, FRCP(C) is a member of the following medical societies: American Paraplegia Society, Canadian Association of Physical Medicine and Rehabilitation, Canadian Medical Association, College of Physicians and Surgeons of Ontario, Ontario Medical Association, and Royal College of Physicians and Surgeons of Canada
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Kat Kolaski, MD, Assistant Professor, Departments of Orthopedic Surgery and Pediatrics, Wake Forest University School of Medicine
Kat Kolaski, MD is a member of the following medical societies: American Academy for Cerebral Palsy and Developmental Medicine and American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

CME Editor

Kelly L Allen, MD, Regional Medical Director, IMX-Medical Management Services
Disclosure: Nothing to disclose.

Chief Editor

Consuelo T Lorenzo, MD, Consulting Staff, Department of Physical Medicine and Rehabilitation, Alegent Health Care, Immanuel Rehabilitation Center
Consuelo T Lorenzo, MD is a member of the following medical societies: American Academy of Physical Medicine and Rehabilitation
Disclosure: Nothing to disclose.

RELATED EMEDICINE ARTICLES
Patient Education
 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.